The validity and test-retest reliability of the Leeds Multiple Sclerosis Quality of Life scale in Turkish patients

被引:5
作者
Akbiyik, Derya Iren [1 ]
Sumbuloglu, Vildan [2 ]
Guney, Zafer [3 ]
Armutlu, Kadriye [4 ]
Korkmaz, Nilufer [5 ]
Keser, Ilke [5 ]
Yuksel, Muazzez Merve
Karabudak, Rana [4 ]
机构
[1] Ankara Oncol Res & Training Hosp, Dept Psychiat, Kolej, Turkey
[2] Zonguldak Karaelmas Univ, Dept Biostat, Kozlu Zonguldak, Turkey
[3] Gazi Univ, Dept Pharmacol, Besevler, Turkey
[4] Hacettepe Univ Hosp, Dept Neurol, Ankara, Turkey
[5] Hacettepe Univ, Phys Therapy & Rehabil Sch, Ankara, Turkey
关键词
measurement; multiple sclerosis; quality of life; reliability; validity; DISABILITY; FATIGUE; PEOPLE; IMPACT;
D O I
10.1097/MRR.0b013e328329820f
中图分类号
R49 [康复医学];
学科分类号
100232 [康复医学];
摘要
The aim of the study was to translate and test the reliability and validity of the Leeds Multiple Sclerosis Quality of Life Scale (LMSQoL) in Turkish patients with multiple sclerosis (MS). Demographic data of MS patients who had a registration in and followed up by a university hospital were recorded. The LMSQoL and Turkish Quality of Life questionnaire were applied to the patients. The internal consistency of the scales was assessed by Cronbach's a coefficient. The validity of LMSQoL was examined by using correlation between the total scores of LMSQoL and Turkish Quality of Life questionnaire. Test-retest reliability was examined by using the correlation for the first and second applications of LMSQoL. Sixty-nine MS patients, (40.6% male, 59.4% female) were enrolled in the study. Cronbach's a coefficient was found as 0.67 for the three positive items of LMSQoL. For the five negative items, Cronbach's a was found as 0.78. The correlation coefficient between the total scores of the scales was 0.80 (P<0.001). The Turkish version of the LMSQoL is a reliable and valid instrument and can be effectively used for measuring the impact of MS on the QoL.
引用
收藏
页码:162 / 166
页数:5
相关论文
共 17 条
[1]
Quality of life in multiple sclerosis: the impact of depression, fatigue and disability [J].
Amato, MP ;
Ponziani, G ;
Rossi, F ;
Liedl, CL ;
Stefanile, C ;
Rossi, L .
MULTIPLE SCLEROSIS JOURNAL, 2001, 7 (05) :340-344
[2]
[Anonymous], QUALITY LIFE ASSESSM
[3]
A review about the impact of multiple sclerosis on health-related quality of life [J].
Benito-León, J ;
Morales, JM ;
Rivera-Navarro, J ;
Mitchell, AJ .
DISABILITY AND REHABILITATION, 2003, 25 (23) :1291-1303
[4]
Developing a disease-specific quality of life measure for people with multiple sclerosis [J].
Ford, HL ;
Gerry, E ;
Tennant, A ;
Whalley, D ;
Haigh, R ;
Johnson, MH .
CLINICAL REHABILITATION, 2001, 15 (03) :247-258
[5]
Does adding MS-specific items to a generic measure (the SF-36) improve measurement? [J].
Freeman, JA ;
Hobart, JC ;
Thompson, AJ .
NEUROLOGY, 2001, 57 (01) :68-74
[6]
Validity and reliability of the Persian version of the multiple sclerosis quality of life questionnaire [J].
Ghaem, H. ;
Borhani-Haghighi, A. ;
Jafari, P. ;
Nikseresht, A. R. .
NEUROLOGY INDIA, 2007, 55 (04) :369-375
[7]
Quality of life measures for the palliative care of people severely affected by multiple sclerosis: a systematic review [J].
Gruenewald, DA ;
Higginson, IJ ;
Vivat, B ;
Edmonds, P ;
Burman, RE .
MULTIPLE SCLEROSIS JOURNAL, 2004, 10 (06) :690-725
[8]
Kaya N., 2003, Anadolu Psikiyatri Dergisi, V4, P220
[9]
Disease-specific quality of life in multiple sclerosis: the effect of disease modifying treatment [J].
Lily, O. ;
McFadden, E. ;
Hensor, E. ;
Johnson, M. ;
Ford, H. .
MULTIPLE SCLEROSIS JOURNAL, 2006, 12 (06) :808-813
[10]
Factors influencing quality of life in multiple sclerosis patients:: disability, depressive mood, fatigue and sleep quality [J].
Lobentanz, IS ;
Asenbaum, S ;
Vass, K ;
Sauter, C ;
Klösch, G ;
Kollegger, H ;
Kristoferitsch, W ;
Zeitlhofer, J .
ACTA NEUROLOGICA SCANDINAVICA, 2004, 110 (01) :6-13